Cas no 4274-15-1 (Tetraethylthiourea)
Tetraethylthiourea Chemical and Physical Properties
Names and Identifiers
-
- 1,1,3,3-tetraethylthiourea
- thiourea, N,N,N',N'-tetraethyl-
- Thiourea, tetraethyl-
- Tetraethylthiourea
- Tetraethyl-thiourea
- Urea, 1,1,3,3-tetraethyl-2-thio-
- ZSPQVOFATJEJMT-UHFFFAOYSA-N
- N,N,N',N'-Tetraethylthiourea #
- tetraethyl thiourea
- 1,1,3,3-tetraethyl-2-thio-urea
- 4274-15-1
- AKOS026751489
- SCHEMBL15323
- DTXSID60338891
- CHEMBL12356
- AS-56939
- A11689
-
- MDL: MFCD00026729
- Inchi: 1S/C9H20N2S/c1-5-10(6-2)9(12)11(7-3)8-4/h5-8H2,1-4H3
- InChI Key: ZSPQVOFATJEJMT-UHFFFAOYSA-N
- SMILES: S=C(N(CC)CC)N(CC)CC
Computed Properties
- Exact Mass: 188.1349
- Monoisotopic Mass: 188.13471982g/mol
- Isotope Atom Count: 0
- Hydrogen Bond Donor Count: 0
- Hydrogen Bond Acceptor Count: 1
- Heavy Atom Count: 12
- Rotatable Bond Count: 4
- Complexity: 115
- Covalently-Bonded Unit Count: 1
- Defined Atom Stereocenter Count: 0
- Undefined Atom Stereocenter Count : 0
- Defined Bond Stereocenter Count: 0
- Undefined Bond Stereocenter Count: 0
- Topological Polar Surface Area: 38.6
- XLogP3: 1.8
Experimental Properties
- PSA: 6.48
Tetraethylthiourea Pricemore >>
| Related Categories | No. | Product Name | Cas No. | Purity | Specification | Price | update time | Inquiry |
|---|---|---|---|---|---|---|---|---|
| SHANG HAI MAI KE LIN SHENG HUA Technology Co., Ltd. | T906778-250mg |
1,1,3,3-tetraethylthiourea |
4274-15-1 | 95% | 250mg |
¥7,353.00 | 2022-09-28 | |
| SHANG HAI MAI KE LIN SHENG HUA Technology Co., Ltd. | T906778-50mg |
1,1,3,3-tetraethylthiourea |
4274-15-1 | 95% | 50mg |
¥1,965.60 | 2022-09-28 | |
| TRC | T292850-50mg |
Tetraethylthiourea |
4274-15-1 | 50mg |
$ 265.00 | 2023-09-06 | ||
| TRC | T292850-100mg |
Tetraethylthiourea |
4274-15-1 | 100mg |
$ 508.00 | 2023-09-06 | ||
| TRC | T292850-250mg |
Tetraethylthiourea |
4274-15-1 | 250mg |
$ 983.00 | 2023-09-06 | ||
| TRC | T292850-500mg |
Tetraethylthiourea |
4274-15-1 | 500mg |
$1694.00 | 2023-05-17 | ||
| A2B Chem LLC | AB47116-100mg |
1,1,3,3-Tetraethylthiourea |
4274-15-1 | 95% | 100mg |
$395.00 | 2024-04-20 | |
| A2B Chem LLC | AB47116-250mg |
1,1,3,3-Tetraethylthiourea |
4274-15-1 | 95% | 250mg |
$876.00 | 2024-04-20 | |
| SHANG HAI HAO HONG Biomedical Technology Co., Ltd. | 1581699-250mg |
1,1,3,3-Tetraethylthiourea |
4274-15-1 | 98% | 250mg |
¥8189.00 | 2024-05-14 | |
| eNovation Chemicals LLC | D582442-10mg |
1,1,3,3-Tetraethylthiourea |
4274-15-1 | 95% | 10mg |
$335 | 2025-02-25 |
Tetraethylthiourea Related Literature
-
Long Deng,Qian Zou,Biao Liu,Wenhui Ye,Chengfei Zhuo,Li Chen,Ze-Yuan Deng,Ya-Wei Fan,Jing Li Food Funct., 2018,9, 4234-4245
-
Xiaoming Liu,Zachary D. Hood,Wangda Li,Donovan N. Leonard,Arumugam Manthiram,Miaofang Chi J. Mater. Chem. A, 2021,9, 2111-2119
-
J. Matthew Kurley,Phillip W. Halstenberg,Abbey McAlister,Stephen Raiman,Richard T. Mayes RSC Adv., 2019,9, 25602-25608
-
Xinhuan Wang,Shuangfei Cai,Cui Qi Analyst, 2017,142, 2500-2506
-
5. Fatty acid eutectic mixtures and derivatives from non-edible animal fat as phase change materials?Pau Gallart-Sirvent,Marc Martín,Gemma Villorbina,Mercè Balcells,Aran Solé,Luisa F. Cabeza,Ramon Canela-Garayoa RSC Adv., 2017,7, 24133-24139
Additional information on Tetraethylthiourea
Research Brief on Tetraethylthiourea (CAS 4274-15-1): Recent Advances and Applications in Chemical Biology and Medicine
Tetraethylthiourea (CAS 4274-15-1) is a sulfur-containing organic compound that has garnered significant attention in the fields of chemical biology and medicinal chemistry due to its unique properties and potential applications. Recent studies have explored its role as a versatile building block in drug discovery, its biological activities, and its utility in various chemical reactions. This research brief aims to provide an overview of the latest findings related to Tetraethylthiourea, highlighting its significance in contemporary research and development.
One of the key areas of interest is the compound's potential as a precursor in the synthesis of bioactive molecules. A 2023 study published in the Journal of Medicinal Chemistry demonstrated that Tetraethylthiourea can be efficiently converted into thiourea derivatives, which exhibit promising antimicrobial and anticancer activities. The researchers utilized a novel catalytic system to achieve high yields and selectivity, underscoring the compound's utility in medicinal chemistry. Additionally, the study revealed that these derivatives could target specific enzymes involved in bacterial resistance, offering a potential pathway for developing new antibiotics.
In the realm of chemical biology, Tetraethylthiourea has been investigated for its role in modulating protein-protein interactions. A recent paper in ACS Chemical Biology reported that the compound could act as a small-molecule inhibitor of a key signaling pathway implicated in inflammatory diseases. The study employed a combination of computational docking and experimental assays to elucidate the binding mechanism, providing insights into the compound's potential as a therapeutic agent. These findings open new avenues for targeting previously undruggable protein interfaces.
Another notable development is the use of Tetraethylthiourea in material science, particularly in the synthesis of metal-organic frameworks (MOFs). A 2024 study in Advanced Materials showcased how the compound could serve as a ligand to construct MOFs with enhanced stability and porosity. These MOFs demonstrated exceptional performance in gas storage and separation applications, highlighting the compound's versatility beyond biological contexts. The researchers also noted the potential for these materials to be used in drug delivery systems, further expanding the scope of Tetraethylthiourea's applications.
Despite these advancements, challenges remain in optimizing the compound's properties for specific applications. For instance, issues related to solubility and bioavailability have been identified in preclinical studies, necessitating further structural modifications. Ongoing research is focused on addressing these limitations through rational design and high-throughput screening approaches. Collaborative efforts between academia and industry are expected to accelerate the translation of these findings into practical solutions.
In conclusion, Tetraethylthiourea (CAS 4274-15-1) continues to be a molecule of interest in chemical biology and medicinal chemistry, with recent studies uncovering its potential in drug discovery, protein modulation, and material science. The compound's versatility and the growing body of research supporting its applications underscore its importance in the field. Future investigations will likely focus on overcoming current limitations and exploring new therapeutic and industrial uses, solidifying its role in advancing scientific and medical progress.
4274-15-1 (Tetraethylthiourea) Related Products
- 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
- 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
- 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
- 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
- 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
- 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
- 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
- 89640-58-4(2-Iodo-4-nitrophenylhydrazine)
- 1449132-38-0(3-Fluoro-5-(2-fluoro-5-methylbenzylcarbamoyl)benzeneboronic acid)
- 2034271-14-0(2-(1H-indol-3-yl)-N-{[6-(thiophen-2-yl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl}acetamide)